TitlePh

20 mai 2019
China has conducted emergency reviews and granted conditional approval for two homegrown drugs for COVID-19 treatment, the National Medical Products Administration said on Sunday.
 Site référencé:  China

China 

TitlePh
22/05/2019
TitlePh
22/05/2019
TitlePh
22/05/2019
TitlePh
22/05/2019
TitlePh
22/05/2019
TitlePh
22/05/2019